Stocks were trying to stage a second day rally on Thursday, with the shenanigans in Greece again being the hope. The reasons vary as to why and what the catalyst is, but investors have lined up and bought every stock market pullback for nearly four years now. 24/7 Wall St. reviews dozens of research reports each morning of the week. The goal is to find new trading and investing ideas for its readers. Some of these analyst calls cover stocks to buy, while others cover stocks to sell or to avoid.

These are this Thursday’s top analyst upgrades, downgrades and initiations.

Chesapeake Energy Corp. (NYSE: CHK) was downgraded to Perform from Outperform at Oppenheimer. That means that the firm now has no target to speak of, and the $13.06 closing price compares to a consensus price target of $15.67 and a 52-week range of $12.89 to $29.92. The downgrade was based on growing losses and a cash flow deficit.

Rite Aid Corp. (NYSE: RAD) was started as Outperform with a $10 price target (versus a $8.64 close) at Credit Suisse. The firm believes Rite Aid is one of the more compelling risk-reward profiles in the space and that it has a compelling M&A potential.

Toll Brothers Inc. (NYSE: TOL) was raised to Outperform from Neutral and the target price was raised to $42 from $40 (versus a $36.81 close) at Credit Suisse. The firm believes that investors underappreciate its earnings potential, and the firm raised estimates to reflect the updated City Living pipeline.

Transocean Ltd. (NYSE: RIG) was started as Underweight with a price target of $14 (versus a $19.08 close) at Barclays. Transocean’s consensus price target is $14.17, and the 52-week range is $13.28 to $46.12.

Harley-Davidson Inc. (NYSE: HOG) was downgraded to Neutral from Outperform with a price target cut to $57.00 from $74.00 (versus a $54.69 close) at Wedbush. Harley-Davidson has a consensus price target of $66.00 and a 52-week range of $53.04 to $72.37.

ALSO READ: Deutsche Bank’s Top 3 Cybersecurity Stocks to Buy

Other key analyst upgrades, downgrades and initiations this Thursday were in shares of the following:

Agenus Inc. (NASDAQ: AGEN) was started as Outperform with a price target of $14.00 (versus a $8.92 close) at Oppenheimer.

Autodesk Inc. (NASDAQ: ADSK) was downgraded to Neutral from Outperform with a price target cut to $57.00 from $64.00 (versus a $54.97 close) at Wedbush.

Bazaarvoice Inc. (NASDAQ: BV) was downgraded to Sector Weight from Overweight at Pacific Crest. Credit Suisse maintained its Outperform rating but cut its target to $9.00 from $10.00 in the call.

Boulder Brands Inc. (NASDAQ: BDBD) was downgraded to Neutral from Buy with a fair value estimate cut down to $7.00 from $11.00 (versus a $6.91 close) at Janney Capital Markets. The firm believes that the management departure is going to make the turnaround longer to achieve.

ALSO READ: 9 Analyst Stocks Under $10 With Huge Upside

Digital Realty Trust Inc. (NYSE: DLR) was raised to Outperform from Neutral and the price target was raised to $73.00 from $70.00 (versus a $65.00 close) at Cowen.

E.W. Scripps Co. (NYSE: SSP) was started as Outperform at Wells Fargo.

Fidelity National Information Services Inc. (NYSE: FIS) was raised to Outperform from Neutral with a $70 price target at R.W. Baird.

Horizon Pharma PLC (NASDAQ: HZNP) was started as Overweight with a $38.00 price target (versus a $31.84 close) at Morgan Stanley.

InterXion Holding N.V. (NASDAQ: INXN) was raised to Outperform from Perform with a $32.00 price target at Oppenheimer, after appointing a new chairman and after two members of the board associated with Baker Capital departed.

Krispy Kreme Doughnuts Inc. (NYSE: KKD) was reiterated as Buy with a fair value estimate of $24.00 (versus a $17.40 close) at Janney Capital Markets. The call is after the doughnut maker beat earnings and slightly raised guidance.

NeoPhotonics Corp. (NASDAQ: NPTN) was raised to Outperform from Market Perform with a price target of $11.00 (versus a $9.25 close) at Raymond James.

Ocean Rig UDW Inc. (NASDAQ: ORIG) was started as Underweight and with a price target of $5.00 (versus a $6.80 close) at Barclays.

PlasmaTech Biopharmaceuticals Inc. (NASDAQ: PTBI) was started as Buy with a price target of $16.00 (versus a $7.07 close) at Roth Capital.

ALSO READ: 10 Stocks to Own for the Next Decade

Credit Suisse has raised its 2015 year-end target for the S&P 500 to 2,200 from 2,170. Also, they see a 60% to 70% chance that there will be a bubble in the equity markets in the medium term, but with bumps along the way.

In case you missed out on Wednesday’s top analyst upgrades and downgrades, they included Cisco Systems, Dollar General, DreamWorks Animation, Google, Lululemon Athletica, Quiksilver and over a dozen others.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.